论文部分内容阅读
目的:观察哮喘患儿的治疗效果。方法:将大理州人民医院2012年2月-2014年5月接收的60例哮喘患儿作为研究对象,随机分为对照组与观察组,每组30例,对照组行孟鲁司特治疗,观察组行氨溴特罗联合孟鲁司特治疗,对比其疗效。结果:两组患儿经治疗后,对照组治疗总有效率(70.0%)明显不及观察组的(96.7%),组间比较,差异具有统计学意义(P<0.05);观察组患儿的生活质量评分明显优于对照组,组间比较,差异具有统计学意义(P<0.05)。结论:哮喘患儿行氨溴特罗联合孟鲁司特治疗的疗效确切。
Objective: To observe the therapeutic effect of asthma in children. Methods: Sixty asthmatic children received from Dali People’s Hospital from February 2012 to May 2014 were randomly divided into control group (n = 30) and observation group (n = 30). The control group was treated with montelukast, The observation group was treated with ambroxol combined with montelukast, and its efficacy was compared. Results: After treatment, the total effective rate (70.0%) in the control group was significantly lower than that in the observation group (96.7%), the difference was statistically significant (P <0.05); in the observation group Quality of life scores were significantly better than the control group, the difference between groups was statistically significant (P <0.05). Conclusion: The efficacy of ambroxol combined with montelukast in children with asthma is definite.